Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215.
Department of Orthopaedics, Beth Israel Deaconess Medical Center, Boston, MA.
AJR Am J Roentgenol. 2021 Apr;216(4):997-1002. doi: 10.2214/AJR.20.23080. Epub 2021 Feb 24.
Diagnostic accuracy of core needle biopsy (CNB) for adipocytic tumors can be low because of sampling error from these often large, heterogeneous lesions. The purpose of this study was to evaluate the diagnostic accuracy of image-guided CNB for various adipocytic tumors in comparison with excisional pathology. Adipocytic tumors ( = 77) of all adult patients undergoing image-guided CNB and subsequent surgical excision of an adipocytic tumor at a tertiary referral center between 2005 and 2019 were studied. To determine concordance, we compared pathologic diagnoses based on CNB to the reference standard of pathologic diagnoses after surgical excision. Tumors were divided into three categories (benign lipomatous tumors [lipoma, lipoma variants, hibernomas], atypical lipomatous tumors [ALTs] or well-differentiated liposarcomas [WDLs], and higher grade liposarcomas [myxoid, dedifferentiated, pleomorphic]), and diagnostic accuracy was calculated for each category. In 73 of 77 adipocytic tumors (95%), diagnosis at CNB and diagnosis after excision were concordant. Accuracy of diagnosis was poorer for ALTs and WDLs than for the other two categories, and the difference was statistically significant ( < .002). For the 29 benign lipomatous tumors and the 27 higher-grade liposarcomas, diagnoses at CNB and after excision were concordant in all cases (100%). Seventeen of the 21 tumors (81%) diagnosed as ALTs or WDLs at CNB had a concordant diagnosis after excision; four of the 21 were upgraded (dedifferentiated liposarcoma, = 3; myxoid liposarcoma, = 1). CNB provides high diagnostic accuracy for adipocytic tumors, particularly for benign lipomatous tumors and higher grade liposarcomas. However, though still high at 81%, diagnostic accuracy of CNB is not as high for tumors diagnosed as ALTs or WDLs. Awareness of this limitation is important when determining management, particularly of cases of ALT or WDL for which surgery is not planned.
核心针活检 (CNB) 对脂肪性肿瘤的诊断准确性可能较低,因为这些肿瘤通常较大且异质性,存在取样误差。本研究旨在评估与手术病理相比,影像学引导下 CNB 对各种脂肪性肿瘤的诊断准确性。
回顾性分析 2005 年至 2019 年在一家三级转诊中心接受影像学引导下 CNB 及随后切除脂肪性肿瘤的所有成年患者的脂肪性肿瘤(=77 例)。为了确定一致性,我们将基于 CNB 的病理诊断与手术切除后的病理诊断标准进行比较。将肿瘤分为三类(良性脂肪性肿瘤[脂肪瘤、脂肪瘤变异体、冬眠瘤]、非典型性脂肪性肿瘤[ALT]或高分化脂肪肉瘤[WDL]和高级别脂肪肉瘤[黏液样、去分化、多形性]),并计算每种类别的诊断准确性。
在 77 例脂肪性肿瘤中,73 例(95%)CNB 与切除后的诊断一致。与其他两种肿瘤相比,ALT 和 WDL 的诊断准确性较差,差异具有统计学意义(<0.002)。29 例良性脂肪瘤和 27 例高级别脂肪肉瘤在 CNB 和切除后诊断均一致(100%)。21 例 ALT 或 WDL 中,17 例(81%)在 CNB 时的诊断与切除后一致;21 例中有 4 例升级(去分化脂肪肉瘤,=3;黏液样脂肪肉瘤,=1)。
CNB 对脂肪性肿瘤具有较高的诊断准确性,尤其是对良性脂肪瘤和高级别脂肪肉瘤。然而,尽管 CNB 对诊断为 ALT 或 WDL 的肿瘤的诊断准确性仍高达 81%,但并不高。在确定治疗方案时,特别是对于不计划手术的 ALT 或 WDL 病例,了解这一局限性非常重要。